According to Stanford University’s AI Index Report , “AI has moved into its era of deployment; throughout 2022 and the beginning of 2023, new large-scale AI models have been released every month.” Exponential Growth in FDA Approval of AI Applications Although Sybil awaits approval by the FDA, 521 AI algorithms have Sybil’s ability to predict cancer outcomes can lead to more widespread screening, especially in underserved populations, which would align with guidance from the U.S.